Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Sep. 30, 2023 | Nov. 08, 2023 | |
Document Information Line Items | ||
Entity Registrant Name | REFLECT SCIENTIFIC, INC. | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Entity Common Stock, Shares Outstanding | 85,214,086 | |
Amendment Flag | false | |
Entity Central Index Key | 0001103090 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Sep. 30, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q3 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 000-31377 | |
Entity Incorporation, State or Country Code | UT | |
Entity Tax Identification Number | 87-0642556 | |
Entity Address, Address Line One | 1266 South 1380 West | |
Entity Address, City or Town | Orem | |
Entity Address, State or Province | UT | |
Entity Address, Postal Zip Code | 84058 | |
City Area Code | (801) | |
Local Phone Number | 226-4100 | |
Title of 12(b) Security | None | |
Entity Interactive Data Current | Yes |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Cash and cash equivalents | $ 1,339,446 | $ 1,381,927 |
Accounts receivable, net | 120,182 | 129,329 |
Inventories, net | 920,954 | 797,352 |
Prepaid expenses and other current assets | 9,693 | 20,221 |
Total Current Assets | 2,390,275 | 2,328,829 |
Operating lease right-of-use assets | 252,955 | 54,265 |
Goodwill | 60,000 | 60,000 |
Other long-term assets | 3,100 | 3,100 |
TOTAL ASSETS | 2,706,330 | 2,446,194 |
Current Liabilities | ||
Accounts payable and accrued expenses | 104,276 | 78,969 |
Customer deposits | 273,834 | 13,230 |
Current portion of operating lease liabilities | 56,298 | 57,393 |
Total Current Liabilities | 434,408 | 149,592 |
Operating lease liabilities, net of current portion | 197,358 | |
TOTAL LIABILITIES | 631,766 | 149,592 |
Stockholders' Equity | ||
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; none issued and outstanding as of September 30, 2023 and December 31, 2022 | ||
Common stock, $0.01 par value, 100,000,000 shares authorized; 85,214,086 shares issued and outstanding as of September 30, 2023 and December 31, 2022 | 852,140 | 852,140 |
Additional paid-in capital | 20,272,806 | 20,252,181 |
Accumulated deficit | (19,050,382) | (18,807,719) |
TOTAL STOCKHOLDERS’ EQUITY | 2,074,564 | 2,296,602 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ 2,706,330 | $ 2,446,194 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares | Sep. 30, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Preferred stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Common stock, par value (in Dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
Common stock, shares issued | 85,214,086 | 85,214,086 |
Common stock, shares outstanding | 85,214,086 | 85,214,086 |
Condensed Consolidated Statemen
Condensed Consolidated Statements Of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Revenues | $ 525,874 | $ 253,233 | $ 891,385 | $ 1,562,424 |
Cost of goods sold | 195,888 | 122,204 | 373,371 | 552,314 |
Gross profit | 329,986 | 131,029 | 518,014 | 1,010,110 |
Operating Expenses | ||||
Salaries and wages | 155,677 | 154,648 | 472,521 | 484,492 |
General and administrative | 84,331 | 94,781 | 272,684 | 315,734 |
Research and development | 9,082 | 14,820 | 20,528 | 58,474 |
Total Operating Expenses | 249,090 | 264,249 | 765,733 | 858,700 |
INCOME (LOSS) FROM OPERATIONS | 80,896 | (133,220) | (247,719) | 151,410 |
Other income | 5,368 | 5,368 | ||
NET INCOME (LOSS) BEFORE INCOME TAXES | 86,264 | (133,220) | (242,351) | 151,410 |
INCOME TAX EXPENSE | (702) | (312) | (702) | |
NET INCOME (LOSS) | $ 86,264 | $ (133,922) | $ (242,663) | $ 150,708 |
Earnings (loss) per common share | ||||
Basic (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 |
Diluted (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 |
Weighted average shares outstanding | ||||
Basic (in Shares) | 85,214,086 | 84,989,086 | 85,214,086 | 84,989,086 |
Diluted (in Shares) | 85,664,086 | 84,989,086 | 85,214,086 | 85,739,086 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) | Common Stock | Additional Paid-In Capital | Accumulated Deficit | Total |
Balance at Dec. 31, 2021 | $ 849,890 | $ 20,226,931 | $ (18,897,115) | $ 2,179,706 |
Balance (in Shares) at Dec. 31, 2021 | 84,989,086 | |||
Stock-based compensation | 12,844 | 12,844 | ||
Net income (loss) | 206,505 | 206,505 | ||
Balance at Mar. 31, 2022 | $ 849,890 | 20,239,775 | (18,690,610) | 2,399,055 |
Balance (in Shares) at Mar. 31, 2022 | 84,989,086 | |||
Balance at Dec. 31, 2021 | $ 849,890 | 20,226,931 | (18,897,115) | 2,179,706 |
Balance (in Shares) at Dec. 31, 2021 | 84,989,086 | |||
Net income (loss) | 150,708 | |||
Balance at Sep. 30, 2022 | $ 849,890 | 20,247,556 | (18,746,407) | 2,351,039 |
Balance (in Shares) at Sep. 30, 2022 | 84,989,086 | |||
Balance at Mar. 31, 2022 | $ 849,890 | 20,239,775 | (18,690,610) | 2,399,055 |
Balance (in Shares) at Mar. 31, 2022 | 84,989,086 | |||
Stock-based compensation | 906 | 906 | ||
Net income (loss) | 78,125 | 78,125 | ||
Balance at Jun. 30, 2022 | $ 849,890 | 20,240,681 | (18,612,485) | 2,478,086 |
Balance (in Shares) at Jun. 30, 2022 | 84,989,086 | |||
Stock-based compensation | 6,875 | 6,875 | ||
Net income (loss) | (133,922) | (133,922) | ||
Balance at Sep. 30, 2022 | $ 849,890 | 20,247,556 | (18,746,407) | 2,351,039 |
Balance (in Shares) at Sep. 30, 2022 | 84,989,086 | |||
Balance at Dec. 31, 2022 | $ 852,140 | 20,252,181 | (18,807,719) | 2,296,602 |
Balance (in Shares) at Dec. 31, 2022 | 85,214,086 | |||
Stock-based compensation | 6,875 | 6,875 | ||
Net income (loss) | (147,839) | (147,839) | ||
Balance at Mar. 31, 2023 | $ 852,140 | 20,259,056 | (18,955,558) | 2,155,638 |
Balance (in Shares) at Mar. 31, 2023 | 85,214,086 | |||
Balance at Dec. 31, 2022 | $ 852,140 | 20,252,181 | (18,807,719) | 2,296,602 |
Balance (in Shares) at Dec. 31, 2022 | 85,214,086 | |||
Net income (loss) | (242,663) | |||
Balance at Sep. 30, 2023 | $ 852,140 | 20,272,806 | (19,050,382) | 2,074,564 |
Balance (in Shares) at Sep. 30, 2023 | 85,214,086 | |||
Balance at Mar. 31, 2023 | $ 852,140 | 20,259,056 | (18,955,558) | 2,155,638 |
Balance (in Shares) at Mar. 31, 2023 | 85,214,086 | |||
Stock-based compensation | 6,875 | 6,875 | ||
Net income (loss) | (181,088) | (181,088) | ||
Balance at Jun. 30, 2023 | $ 852,140 | 20,265,931 | (19,136,646) | 1,981,425 |
Balance (in Shares) at Jun. 30, 2023 | 85,214,086 | |||
Stock-based compensation | 6,875 | 6,875 | ||
Net income (loss) | 86,264 | 86,264 | ||
Balance at Sep. 30, 2023 | $ 852,140 | $ 20,272,806 | $ (19,050,382) | $ 2,074,564 |
Balance (in Shares) at Sep. 30, 2023 | 85,214,086 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2023 | Sep. 30, 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net income (loss) | $ (242,663) | $ 150,708 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Stock-based compensation | 20,625 | 20,625 |
Amortization of right-of-use assets | 44,192 | 41,885 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 9,147 | 60,088 |
Inventories | (123,602) | (279,590) |
Prepaid expenses and other current assets | 10,528 | 15,876 |
Accounts payable and accrued expenses | 25,307 | (7,479) |
Customer deposits | 260,604 | (109,552) |
Operating lease liabilities | (46,619) | (41,779) |
Net cash used in operating activities | (42,481) | (149,218) |
CASH FLOWS FROM INVESTING ACTIVITIES | ||
Net cash provided by investing activities | ||
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Net cash provided by financing activities | ||
NET CHANGE IN CASH AND CASH EQUIVALENTS | (42,481) | (149,218) |
CASH AND CASH EQUIVALENTS | ||
Beginning of the period | 1,381,927 | 1,473,924 |
End of the period | 1,339,446 | 1,324,706 |
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION | ||
Cash paid for interest | ||
Cash paid for income taxes | ||
NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
Operating lease right-of-use asset and liability remeasurement | $ 242,882 |
Basis of Presentation
Basis of Presentation | 9 Months Ended |
Sep. 30, 2023 | |
Basis of Presentation [Abstract] | |
BASIS OF PRESENTATION | NOTE 1—BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Reflect Scientific, Inc. (the “Company,” “we,” “us,” or “our”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q of Regulation S-X. They do not include all the information and footnotes required by GAAP for complete financial statements. The December 31, 2022, consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. However, except as disclosed herein, there has been no material change in the information disclosed in the notes to the consolidated financial statements for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on March 31, 2023. The interim unaudited condensed consolidated financial statements should be read in conjunction with those consolidated financial statements included in the Form 10-K. In the opinion of management, all adjustments considered necessary for a fair presentation of the financial statements, consisting solely of normal recurring adjustments, have been made. Operating results for the three and nine months ended September 30, 2023, are not necessarily indicative of the results that may be expected for the year ending December 31, 2023. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2023 | |
Recent Accounting Pronouncements [Abstract] | |
RECENT ACCOUNTING PRONOUNCEMENTS | NOTE 2—RECENT ACCOUNTING PRONOUNCEMENTS The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). The Company has evaluated all recent accounting pronouncements and determined that the adoption of pronouncements applicable to the Company has not had or is not expected to have a material impact on the Company's condensed consolidated financial statements. |
Disaggregation of Revenues
Disaggregation of Revenues | 9 Months Ended |
Sep. 30, 2023 | |
Disaggregation of Revenues [Abstract] | |
DISAGGREGATION OF REVENUES | NOTE 3—DISAGGREGATION OF REVENUES Our revenue is disaggregated based on product category and geographical region. We recognize revenue from the sale of scientific equipment for the life sciences and manufacturing industries. Our products range from non-mechanical Cyrometrix freezers, chillers, and original equipment manufacturer (“OEM”) value-added products and components for the life sciences industry. The Company’s revenues for the three months ended September 30, 2023 and 2022 are disaggregated as follows: Three Months Ended September 30, 2023 United States International Total Revenues Freezers and chillers $ 355,561 $ - $ 355,561 OEM and other 122,980 47,333 170,313 Total Revenues $ 478,541 $ 47,333 $ 525,874 Three Months Ended September 30, 2022 United States International Total Revenues Freezers and chillers $ 54,768 $ - $ 54,768 OEM and other 129,695 68,770 198,465 Total Revenues $ 184,463 $ 68,770 $ 253,233 The Company’s revenues for the nine months ended September 30, 2023 and 2022 are disaggregated as follows: Nine Months Ended September 30, 2023 United States International Total Revenues Freezers and chillers $ 411,319 $ - $ 411,319 OEM and other 332,015 148,051 480,066 Total Revenues $ 743,334 $ 148,051 $ 891,385 Nine Months Ended September 30, 2022 United States International Total Revenues Freezers and chillers $ 712,930 $ 153,236 $ 866,166 OEM and other 497,742 198,516 696,258 Total Revenues $ 1,210,672 $ 351,752 $ 1,562,424 |
Inventories
Inventories | 9 Months Ended |
Sep. 30, 2023 | |
Inventories [Abstract] | |
INVENTORIES | NOTE 4—INVENTORIES Inventories at September 30, 2023 and December 31, 2022 consisted of the following: September 30, December 31, 2023 2022 Finished goods $ 297,768 $ 376,334 Raw materials 729,230 527,062 Total inventories 1,026,998 903,396 Less reserve for obsolescence (106,044 ) (106,044 ) Total inventories, net $ 920,954 $ 797,352 Inventory balances are composed of finished goods and raw materials. Work in process inventory is immaterial to the condensed consolidated financial statements. |
Leases
Leases | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
LEASES | NOTE 5—LEASES The following was included in our condensed consolidated balance sheets at September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Operating lease right-of-use assets $ 252,955 $ 54,265 Lease liabilities, current portion 56,298 57,393 Lease liabilities, long-term 197,358 - Total operating lease liabilities $ 253,656 $ 57,393 Weighted-average remaining lease term (months) 38 11 Weighted average discount rate 10.50 % 5.25 % Total lease expense for the three and nine months ended September 30, 2023 and 2022 is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease expense $ 15,216 $ 15,216 $ $45,648 $ 45,648 Variable lease expense 5,300 1,334 16,939 5,122 Total lease expense $ 20,516 $ 16,550 $ 62,587 $ 50,770 As of September 30, 2023, maturities of operating lease liabilities were as follows: Year Ending December 31, Amount 2023 – remaining $ 17,587 2024 85,309 2025 98,532 2026 101,708 Total 303,136 Less: imputed interest (49,480 ) Total operating lease liabilities $ 253,656 |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Sep. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
STOCKHOLDERS’ EQUITY | NOTE 6—STOCKHOLDERS’ EQUITY Common Stock As of September 30, 2023, the Company was authorized to issue 100,000,000 common shares. As of September 30, 2023 and December 31, 2022, the Company had 85,214,086 common shares issued and outstanding. Restricted Stock Awards Below is a table summarizing the changes in restricted stock awards outstanding during the nine months ended September 30, 2023: Restricted Stock Awards Weighted-Average Exercise Price Outstanding at December 31, 2022 450,000 $ 0.11 Granted - - Vested - - Forfeited - - Outstanding at September 30, 2023 450,000 $ 0.11 Stock-based compensation expense of $6,875 was recorded during the three months ended September 30, 2023 and 2022, respectively. Stock-based compensation expense of $20,625 was recorded during the nine months ended September 30, 2023 and 2022, respectively. As of September 30, 2023, the remaining unrecognized stock-based compensation expense related to non-vested restricted stock awards is $34,375 and is expected to be recognized over 1.25 years. |
Earnings (Loss) Per Share
Earnings (Loss) Per Share | 9 Months Ended |
Sep. 30, 2023 | |
Earnings (Loss) Per Share [Abstract] | |
EARNINGS (LOSS) PER SHARE | NOTE 7—EARNINGS (LOSS) PER SHARE The computation of the basic and diluted weighted average shares outstanding and the basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2023 and 2022 consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net income (loss) $ 86,264 $ (133,922 ) $ (242,663 ) $ 150,708 Basic weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Basic earnings (loss) per share $ 0.00 $ (0.00 ) $ (0.00 ) $ 0.00 Weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Effect on dilutive stock awards 450,000 - - 750,000 Diluted weighted average shares outstanding 85,664,086 84,989,086 85,214,086 85,739,086 Diluted earnings (loss) per share $ 0.00 $ (0.00 ) $ (0.00 ) $ 0.00 For the nine months ended September 30, 2023, there were 450,000 common share equivalents excluded from the diluted earnings per share calculation as their effect is anti-dilutive. |
Disaggregation of Revenues (Tab
Disaggregation of Revenues (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Disaggregation of Revenues [Abstract] | |
Schedule of Disaggregated Revenues | The Company’s revenues for the three months ended September 30, 2023 and 2022 are disaggregated as follows: Three Months Ended September 30, 2023 United States International Total Revenues Freezers and chillers $ 355,561 $ - $ 355,561 OEM and other 122,980 47,333 170,313 Total Revenues $ 478,541 $ 47,333 $ 525,874 Three Months Ended September 30, 2022 United States International Total Revenues Freezers and chillers $ 54,768 $ - $ 54,768 OEM and other 129,695 68,770 198,465 Total Revenues $ 184,463 $ 68,770 $ 253,233 Nine Months Ended September 30, 2023 United States International Total Revenues Freezers and chillers $ 411,319 $ - $ 411,319 OEM and other 332,015 148,051 480,066 Total Revenues $ 743,334 $ 148,051 $ 891,385 Nine Months Ended September 30, 2022 United States International Total Revenues Freezers and chillers $ 712,930 $ 153,236 $ 866,166 OEM and other 497,742 198,516 696,258 Total Revenues $ 1,210,672 $ 351,752 $ 1,562,424 |
Inventories (Tables)
Inventories (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Inventories [Abstract] | |
Schedule of Inventories | Inventories at September 30, 2023 and December 31, 2022 consisted of the following: September 30, December 31, 2023 2022 Finished goods $ 297,768 $ 376,334 Raw materials 729,230 527,062 Total inventories 1,026,998 903,396 Less reserve for obsolescence (106,044 ) (106,044 ) Total inventories, net $ 920,954 $ 797,352 |
Leases (Tables)
Leases (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Leases [Abstract] | |
Schedule of Consolidated Balance Sheet | The following was included in our condensed consolidated balance sheets at September 30, 2023 and December 31, 2022: September 30, December 31, 2023 2022 Operating lease right-of-use assets $ 252,955 $ 54,265 Lease liabilities, current portion 56,298 57,393 Lease liabilities, long-term 197,358 - Total operating lease liabilities $ 253,656 $ 57,393 Weighted-average remaining lease term (months) 38 11 Weighted average discount rate 10.50 % 5.25 % |
Schedule of Lease Expense | Total lease expense for the three and nine months ended September 30, 2023 and 2022 is as follows: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease expense $ 15,216 $ 15,216 $ $45,648 $ 45,648 Variable lease expense 5,300 1,334 16,939 5,122 Total lease expense $ 20,516 $ 16,550 $ 62,587 $ 50,770 |
Schedule of Maturities of Operating Lease Liabilities | As of September 30, 2023, maturities of operating lease liabilities were as follows: Year Ending December 31, Amount 2023 – remaining $ 17,587 2024 85,309 2025 98,532 2026 101,708 Total 303,136 Less: imputed interest (49,480 ) Total operating lease liabilities $ 253,656 |
Stockholders' Equity (Tables)
Stockholders' Equity (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Changes in Restricted Stock Awards Outstanding | Below is a table summarizing the changes in restricted stock awards outstanding during the nine months ended September 30, 2023: Restricted Stock Awards Weighted-Average Exercise Price Outstanding at December 31, 2022 450,000 $ 0.11 Granted - - Vested - - Forfeited - - Outstanding at September 30, 2023 450,000 $ 0.11 |
Earnings (Loss) Per Share (Tabl
Earnings (Loss) Per Share (Tables) | 9 Months Ended |
Sep. 30, 2023 | |
Earnings (Loss) Per Share [Abstract] | |
Schedule of Weighted Average Shares Outstanding and the Basic and Diluted Earnings Per Share | The computation of the basic and diluted weighted average shares outstanding and the basic and diluted earnings (loss) per share for the three and nine months ended September 30, 2023 and 2022 consisted of the following: Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Net income (loss) $ 86,264 $ (133,922 ) $ (242,663 ) $ 150,708 Basic weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Basic earnings (loss) per share $ 0.00 $ (0.00 ) $ (0.00 ) $ 0.00 Weighted average shares outstanding 85,214,086 84,989,086 85,214,086 84,989,086 Effect on dilutive stock awards 450,000 - - 750,000 Diluted weighted average shares outstanding 85,664,086 84,989,086 85,214,086 85,739,086 Diluted earnings (loss) per share $ 0.00 $ (0.00 ) $ (0.00 ) $ 0.00 |
Disaggregation of Revenues (Det
Disaggregation of Revenues (Details) - Schedule of Disaggregated Revenues - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Revenues | ||||
Total Revenues | $ 525,874 | $ 253,233 | $ 891,385 | $ 1,562,424 |
United States [Member] | ||||
Revenues | ||||
Total Revenues | 478,541 | 184,463 | 743,334 | 1,210,672 |
International [Member] | ||||
Revenues | ||||
Total Revenues | 47,333 | 68,770 | 148,051 | 351,752 |
Freezers and Chillers [Member] | ||||
Revenues | ||||
Total Revenues | 355,561 | 54,768 | 411,319 | 866,166 |
Freezers and Chillers [Member] | United States [Member] | ||||
Revenues | ||||
Total Revenues | 355,561 | 54,768 | 411,319 | 712,930 |
Freezers and Chillers [Member] | International [Member] | ||||
Revenues | ||||
Total Revenues | 153,236 | |||
OEM and Other [Member] | ||||
Revenues | ||||
Total Revenues | 170,313 | 198,465 | 480,066 | 696,258 |
OEM and Other [Member] | United States [Member] | ||||
Revenues | ||||
Total Revenues | 122,980 | 129,695 | 332,015 | 497,742 |
OEM and Other [Member] | International [Member] | ||||
Revenues | ||||
Total Revenues | $ 47,333 | $ 68,770 | $ 148,051 | $ 198,516 |
Inventories (Details) - Schedul
Inventories (Details) - Schedule of Inventories - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Schedule of inventories [Abstract] | ||
Finished goods | $ 297,768 | $ 376,334 |
Raw materials | 729,230 | 527,062 |
Total inventories | 1,026,998 | 903,396 |
Less reserve for obsolescence | (106,044) | (106,044) |
Total inventories, net | $ 920,954 | $ 797,352 |
Leases (Details) - Schedule of
Leases (Details) - Schedule of Consolidated Balance Sheet - USD ($) | Sep. 30, 2023 | Dec. 31, 2022 |
Schedule of Condensed Consolidated Balance Sheet [Abstract] | ||
Operating lease right-of-use assets | $ 252,955 | $ 54,265 |
Lease liabilities, current portion | 56,298 | 57,393 |
Lease liabilities, long-term | 197,358 | |
Total operating lease liabilities | $ 253,656 | $ 57,393 |
Weighted-average remaining lease term (months) | 38 months | 11 months |
Weighted average discount rate | 10.50% | 5.25% |
Leases (Details) - Schedule o_2
Leases (Details) - Schedule of Lease Expense - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Schedule of Lease Expense [Abstract] | ||||
Operating lease expense | $ 15,216 | $ 15,216 | $ 45,648 | $ 45,648 |
Variable lease expense | 5,300 | 1,334 | 16,939 | 5,122 |
Total lease expense | $ 20,516 | $ 16,550 | $ 62,587 | $ 50,770 |
Leases (Details) - Schedule o_3
Leases (Details) - Schedule of Maturities of Operating Lease Liabilities - Operating Lease Liabilities [Member] | Sep. 30, 2023 USD ($) |
Schedule of Maturities of Operating Lease Liabilities [Abstract] | |
2023 – remaining | $ 17,587 |
2024 | 85,309 |
2025 | 98,532 |
2026 | 101,708 |
Total | 303,136 |
Less: imputed interest | (49,480) |
Total operating lease liabilities | $ 253,656 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2022 | |
Stockholders' Equity Note [Abstract] | |||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | 100,000,000 | ||
Common stock, shares issued | 85,214,086 | 85,214,086 | 85,214,086 | ||
Common stock, shares outstanding | 85,214,086 | 85,214,086 | 85,214,086 | ||
Stock based compensation expense | $ 6,875 | $ 6,875 | $ 20,625 | $ 20,625 | |
Unrecognized stock-based compensation expense | $ 34,375 | $ 34,375 | |||
Unrecognized stock-based compensation expense expected to be recognized over period | 1 year 3 months |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - Schedule of Changes in Restricted Stock Awards Outstanding | 9 Months Ended |
Sep. 30, 2023 $ / shares shares | |
Schedule of Changes in Restricted Stock Awards Outstanding [Abstract] | |
Restricted Stock Awards Outstanding, Beginning | shares | 450,000 |
Weighted-Average Exercise Price Outstanding, Beginning | $ / shares | $ 0.11 |
Restricted Stock Awards Outstanding, Granted | shares | |
Weighted-Average Exercise Price Outstanding, Granted | $ / shares | |
Restricted Stock Awards, Vested | shares | |
Weighted-Average Exercise Price, Vested | $ / shares | |
Restricted Stock Awards, Forfeited | shares | |
Weighted-Average Exercise Price Outstanding, Forfeited | $ / shares | |
Restricted Stock Awards Outstanding, Ending | shares | 450,000 |
Weighted-Average Exercise Price Outstanding, Ending | $ / shares | $ 0.11 |
Earnings (Loss) Per Share (Deta
Earnings (Loss) Per Share (Details) | 9 Months Ended |
Sep. 30, 2023 shares | |
Earnings (Loss) Per Share [Abstract] | |
Common share equivalents | 450,000 |
Earnings (Loss) Per Share (De_2
Earnings (Loss) Per Share (Details) - Schedule of Weighted Average Shares Outstanding and the Basic and Diluted Earnings Per Share - USD ($) | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2023 | Jun. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Schedule of Weighted Average Shares Outstanding and the Basic and Diluted Earnings Per Share [Abstract] | ||||||||
Net income (loss) (in Dollars) | $ 86,264 | $ (181,088) | $ (147,839) | $ (133,922) | $ 78,125 | $ 206,505 | $ (242,663) | $ 150,708 |
Basic weighted average shares outstanding | 85,214,086 | 84,989,086 | 85,214,086 | 84,989,086 | ||||
Basic earnings (loss) per share (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 | ||||
Weighted average shares outstanding | 85,214,086 | 84,989,086 | 85,214,086 | 84,989,086 | ||||
Effect on dilutive stock awards (in Dollars) | $ 450,000 | $ 750,000 | ||||||
Diluted weighted average shares outstanding | 85,664,086 | 84,989,086 | 85,214,086 | 85,739,086 | ||||
Diluted earnings (loss) per share (in Dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 |